NYU Langone Health: Cognitive Dysfunction trials

The registry lists 13 Cognitive Dysfunction studies with NYU Langone Health as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 1Phase 3 1Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Innate Immunity Stimulation Via TLR9 in Early ADRecruitingNCT05606341Phase 1
• Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical TrialCompletedNCT00835159Phase 4Results posted
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction TrialSuspendedNCT06566183Phase 3
• Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive ImpairmentCompletedNCT05601583Phase 1
• Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)Active, not recruitingNCT04784416Phase 2
• Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive ImpairmentCompletedNCT03912571
• A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 FlutemetamolTerminatedNCT03274817Phase 1
• The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum DisordersCompletedNCT03166098
• Cognitive Detection of Preclinical AD: Validation Using BiomarkersCompletedNCT02616679
• Neurotrack Test Validation ProtocolCompletedNCT02608021
• An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer SurvivorsCompletedNCT02515487Not applicable
• Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot StudyCompletedNCT01737658Not applicable
• Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloidsCompletedNCT00850928